Jia X, Knight C. Modelling considerations for evaluating the cost-effectiveness of biologics in eosinophilic-associated diseases. Poster presented at the ISPOR Europe 2023; November 15, 2023. Copenhagen, Denmark.
Hillmen P, Jia X, Knight C, Sarda S, Mody-Patel N, Intorcia M, Dingli D. Model structure considerations for cost-effectiveness evaluation of C3 inhibitor pegcetacoplan versus C5 inhibitor in patients with paroxysmal nocturnal hemoglobinuria. Poster presented at the 2021 Virtual AMCP; April 2021.